Coumarin and Piperazine Conjugates as Selective Inhibitors of the Tumor-associated Carbonic Anhydrase IX and XII Isoforms


Citar

Texto integral

Resumo

Background: Carbonic Anhydrases (CAs) are a family of metalloenzymes that catalyze the reversible interconversion of CO2 and water to bicarbonate and proton. CA isoforms I, II, IX, and XII are considered physiologically and pharmacologically relevant.

Objective: The objective of this study is to synthesize potent and selective tumor-associated CA IX and XII inhibitors.

Methods: A library of 17 coumarin derivatives clubbed with piperazine and benzyl moiety was designed, synthesized and evaluated for its inhibitory effects and selectivity profile towards physiologically and pharmacologically relevant CA isoforms I, II, IX, and XII.

Results: All the derivatives were found to be active against the tumor-associated isoforms IX and XII. The most active compound against hCA (human Carbonic Anhydrase) IX was found to possess a Ki of 229 nM, while the one against hCA XII had a Ki of 294.2 nM. Additionally, two of the compounds were found to have exquisite selectivity towards the off-target hCA I and II isoforms. Moreover, they were found to be approximately 20-fold more selective towards hCA IX than XII. The selectivity of the compounds was further investigated via molecular modeling techniques.

Conclusion: Coumarin-piperazine hybrids were identified as potent and selective CA IX and XII inhibitors. Molecular modeling techniques provided interesting cues pertaining to observed selectivity.

Sobre autores

Aaftaab Sethi

Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research

Email: info@benthamscience.net

Sharon Munagalasetty

Department of Medicinal Chemistry, National Institute of Pharmaceutical Education & Research

Email: info@benthamscience.net

Mohammed Arifuddin

Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research

Email: info@benthamscience.net

Simone Carradori

Department of Pharmacy, G. d'Annunzio University of Chieti-Pescar

Email: info@benthamscience.net

Claudiu Supuran

Neurofarba Department, Sezione di Scienze Farmaceutiche e Nutraceutiche, Laboratorio di Chimica Bioinorganica,, Università degli Studi di Firenze

Autor responsável pela correspondência
Email: info@benthamscience.net

Ravi Alvala

Department of Biotechnology, G. Pulla Reddy College of Pharmacy

Email: info@benthamscience.net

Mallika Alvala

Department of Medicinal Chemistry, National Institute of Pharmaceutical Education & Research

Autor responsável pela correspondência
Email: info@benthamscience.net

Bibliografia

  1. Weis, V.M.; Smith, G.J.; Muscatine, L.A. "CO2 supply" mechanism in zooxanthellate cnidarians: Role of carbonic anhydrase. Mar. Biol., 1989, 100(2), 195-202. doi: 10.1007/BF00391958
  2. Supuran, C.T. Carbonic anhydrases: Novel therapeutic applications for inhibitors and activators. Nat. Rev. Drug Discov., 2008, 7(2), 168-181. doi: 10.1038/nrd2467 PMID: 18167490
  3. Supuran, C.T. Structure and function of carbonic anhydrases. Biochem. J., 2016, 473(14), 2023-2032. doi: 10.1042/BCJ20160115 PMID: 27407171
  4. Scozzafava, A.; Mastrolorenzo, A.; Supuran, C.T. Modulation of carbonic anhydrase activity and its applications in therapy. Expert Opin. Ther. Pat., 2004, 14(5), 667-702. doi: 10.1517/13543776.14.5.667
  5. Supuran, C.T. Multitargeting approaches involving carbonic anhydrase inhibitors: Hybrid drugs against a variety of disorders. J. Enzyme Inhib. Med. Chem., 2021, 36(1), 1702-1714. doi: 10.1080/14756366.2021.1945049 PMID: 34325588
  6. Supuran, C.T. Experimental carbonic anhydrase inhibitors for the treatment of hypoxic tumors. J. Exp. Pharmacol., 2020, 12, 603-617. doi: 10.2147/JEP.S265620 PMID: 33364855
  7. Supuran, C.T.; Alterio, V.; Di Fiore, A.; D' Ambrosio, K.; Carta, F.; Monti, S.M.; De Simone, G. Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: Three for the price of one. Med. Res. Rev., 2018, 38(6), 1799-1836. doi: 10.1002/med.21497 PMID: 29635752
  8. Sarnella, A.; Ferrara, Y.; Auletta, L.; Albanese, S.; Cerchia, L.; Alterio, V.; De Simone, G.; Supuran, C.T.; Zannetti, A. Inhibition of carbonic anhydrases IX/XII by SLC-0111 boosts cisplatin effects in hampering head and neck squamous carcinoma cell growth and invasion. J. Exp. Clin. Cancer Res., 2022, 41(1), 122. doi: 10.1186/s13046-022-02345-x PMID: 35365193
  9. Supuran, C.T. How many carbonic anhydrase inhibition mechanisms exist? J. Enzyme Inhib. Med. Chem., 2016, 31(3), 345-360. doi: 10.3109/14756366.2015.1122001 PMID: 26619898
  10. Thacker, P.S.; Angeli, A.; Argulwar, O.S.; Tiwari, P.L.; Arifuddin, M.; Supuran, C.T. Design, synthesis and biological evaluation of coumarin linked 1,2,4-oxadiazoles as selective carbonic anhydrase IX and XII inhibitors. Bioorg. Chem., 2020, 98, 103739. doi: 10.1016/j.bioorg.2020.103739 PMID: 32193032
  11. Mohammed, A.; Supuran, C.T.; Thacker, P.S.; Tiwari, P.L.; Goud, N.S.; Srikanth, D.; Angeli, A. Synthesis and biological evaluation of coumarin carboxamides as selective and potent inhibitors of carbonic anhydrases IX and XII. Anticancer. Agents Med. Chem., 2022, 22(14), 2647-2654. doi: 10.2174/1871520622666220304184525 PMID: 35249507
  12. Sethi, A.; Sasikala, K.; Jakkula, P.; Gadde, D.; Sanam, S.; Qureshi, I.A.; Talla, V.; Alvala, M. Design, synthesis and computational studies involving Indole-Coumarin hybrids as galectin-1 inhibitors. Chem. Pap., 2021, 75(6), 2791-2805. doi: 10.1007/s11696-021-01534-w
  13. Komal, D.; Khushboo, J.; Aaftaab, S.; Lakshmi, S.; Mallika, A. Targeting integrase enzyme: A therapeutic approach to combat HIV resistance. Mini Rev. Med. Chem., 2020, 20(3), 219-238. doi: 10.2174/1389557519666191015124932 PMID: 31613727
  14. Keri, R.S.; Sasidhar, B.S.; Nagaraja, B.M.; Santos, M.A. Recent progress in the drug development of coumarin derivatives as potent antituberculosis agents. Eur. J. Med. Chem., 2015, 100, 257-269. doi: 10.1016/j.ejmech.2015.06.017 PMID: 26112067
  15. Gumus, A.; Bozdag, M.; Akdemir, A.; Angeli, A.; Selleri, S.; Carta, F.; Supuran, C.T. Thiosemicarbazide-substituted coumarins as selective inhibitors of the tumor associated human carbonic anhydrases IX and XII. Molecules, 2022, 27(14), 4610. doi: 10.3390/molecules27144610 PMID: 35889480
  16. Onyılmaz, M.; Koca, M.; Bonardi, A.; Degirmenci, M.; Supuran, C.T. Isocoumarins: A new class of selective carbonic anhydrase IX and XII inhibitors. J. Enzyme Inhib. Med. Chem., 2022, 37(1), 743-748. doi: 10.1080/14756366.2022.2041630 PMID: 35188025
  17. Davis, R.A.; Vullo, D.; Maresca, A.; Supuran, C.T.; Poulsen, S.A. Natural product coumarins that inhibit human carbonic anhydrases. Bioorg. Med. Chem., 2013, 21(6), 1539-1543. doi: 10.1016/j.bmc.2012.07.021 PMID: 22892213
  18. Carta, F.; Maresca, A.; Scozzafava, A.; Supuran, C.T. Novel coumarins and 2-thioxo-coumarins as inhibitors of the tumor-associated carbonic anhydrases IX and XII. Bioorg. Med. Chem., 2012, 20(7), 2266-2273. doi: 10.1016/j.bmc.2012.02.014 PMID: 22377674
  19. Maresca, A.; Temperini, C.; Pochet, L.; Masereel, B.; Scozzafava, A.; Supuran, C.T. Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins. J. Med. Chem., 2010, 53(1), 335-344. doi: 10.1021/jm901287j PMID: 19911821
  20. Sethi, A.; Sanam, S.; Alvala, M. Non-carbohydrate strategies to inhibit lectin proteins with special emphasis on galectins. Eur. J. Med. Chem., 2021, 222, 113561. doi: 10.1016/j.ejmech.2021.113561 PMID: 34146913
  21. Havránková, E.; Csöllei, J.; Vullo, D.; Garaj, V.; Pazdera, P.; Supuran, C.T. Novel sulfonamide incorporating piperazine, aminoalcohol and 1,3,5-triazine structural motifs with carbonic anhydrase I, II and IX inhibitory action. Bioorg. Chem., 2018, 77, 25-37. doi: 10.1016/j.bioorg.2017.12.034 PMID: 29324250
  22. Manasa, K.L.; Pujitha, S.; Sethi, A.; Arifuddin, M.; Alvala, M.; Angeli, A.; Supuran, C.T. Synthesis and biological evaluation of imidazo2,1-bthiazole based sulfonyl piperazines as novel carbonic anhydrase ii inhibitors. Metabolites, 2020, 10(4), 136. doi: 10.3390/metabo10040136 PMID: 32244413
  23. D'Ambrosio, K.; Di Fiore, A.; Buonanno, M.; Kumari, S.; Tiwari, M.; Supuran, C.T.; Mishra, C.B.; Monti, S.M.; De Simone, G. The crystal structures of 2-(4-benzhydrylpiperazin-1-yl)-N-(4-sulfamoylphenyl)acetamide in complex with human carbonic anhydrase II and VII provide insights into selective CA inhibitor development. New J. Chem., 2021, 45(1), 147-152. doi: 10.1039/D0NJ03544K
  24. D'Ambrosio, K.; Carradori, S.; Monti, S.M.; Buonanno, M.; Secci, D.; Vullo, D.; Supuran, C.T.; De Simone, G. Out of the active site binding pocket for carbonic anhydrase inhibitors. Chem. Commun., 2015, 51(2), 302-305. doi: 10.1039/C4CC07320G PMID: 25407638
  25. Pontecorvi, V.; Mori, M.; Picarazzi, F.; Zara, S.; Carradori, S.; Cataldi, A.; Angeli, A.; Berrino, E.; Chimenti, P.; Ciogli, A.; Secci, D.; Guglielmi, P.; Supuran, C.T. Novel insights on human carbonic anhydrase inhibitors based on coumalic acid: Design, synthesis, molecular modeling investigation, and biological studies. Int. J. Mol. Sci., 2022, 23(14), 7950. doi: 10.3390/ijms23147950 PMID: 35887299
  26. Mancuso, F.; De Luca, L.; Angeli, A.; Del Prete, S.; Capasso, C.; Supuran, C.T.; Gitto, R. Synthesis, computational studies and assessment of in vitro inhibitory activity of umbelliferon-based compounds against tumour-associated carbonic anhydrase isoforms IX and XII. J. Enzyme Inhib. Med. Chem., 2020, 35(1), 1442-1449. doi: 10.1080/14756366.2020.1786821 PMID: 32614678
  27. Akdemir, A.; Güzel-Akdemir, Ö.; Demir-Yazıcı, K.; Vullo, D.; Supuran, C.T. New pyridinium salt derivatives of 2-(hydrazinocarbonyl)-3-phenyl-1h-indole-5-sulfonamide as selective inhibitors of tumour-related human carbonic anhydrase isoforms IX and XII. Anticancer. Agents Med. Chem., 2022, 22(14), 2637-2646. doi: 10.2174/1871520622666220207092123 PMID: 35135455
  28. Kockar, F.; Maresca, A.; Aydın, M.; Işık, S.; Turkoglu, S.; Sinan, S.; Arslan, O.; Güler, Ö.Ö.; Turan, Y.; Supuran, C.T Mutation of phe91 to asn in human carbonic anhydrase i unexpectedly enhanced both catalytic activity and affinity for sulfonamide inhibitors. Bioorg. Med. Chem., 2010, 18(15), 5498-5503. doi: 10.1016/j.bmc.2010.06.056 PMID: 20624682

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Bentham Science Publishers, 2023